Sickle Cell Salvation: The Victoria Gray Interview

In July 2019, Victoria Gray, a young mother of four from Forest, Mississippi, became the first patient to receive a CRISPR-based therapy for sickle cell disease (SCD) through the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. 

Source: GEN